Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,382,189
-
Number of holders
-
219
-
Total 13F shares, excl. options
-
45,529,610
-
Shares change
-
-894,964
-
Total reported value, excl. options
-
$1,226,168,208
-
Value change
-
-$38,883,046
-
Put/Call ratio
-
201%
-
Number of buys
-
95
-
Number of sells
-
-92
-
Price
-
$26.93
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q1 2020
266 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q1 2020.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 219 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45,529,610 shares
of 46,382,189 outstanding shares and own 98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5,420,475 shares), VANGUARD GROUP INC (4,615,045 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,326,762 shares), Champlain Investment Partners, LLC (3,434,370 shares), Paradice Investment Management LLC (2,578,462 shares), DIMENSIONAL FUND ADVISORS LP (2,358,166 shares), WELLINGTON MANAGEMENT GROUP LLP (2,250,121 shares), STATE STREET CORP (1,783,254 shares), VICTORY CAPITAL MANAGEMENT INC (1,662,621 shares), and MACQUARIE GROUP LTD (1,554,837 shares).
This table shows the top 219 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.